1-苄基-4-丁基哌啶-4-醇 | 22093-36-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 中文名称: 1-苄基-4-丁基哌啶-4-醇
• 英文名称: 1-Benzyl-4-hydroxy-4-butylpiperidine
• 英文别名: 1-benzyl-4-butylpiperidin-4-ol；1-Benzyl4-butyl-piperidin-4-ol；1-benzyl-4-butyl-piperidin-4-ol；1-Benzyl-4-butyl-4-piperidinol；1-Benzyl-4-butylpiperidinol
• CAS: 22093-36-3
• 化学式: C₁₆H₂₅NO
• 分子量: 247.381
• InChiKey: KTLNULDALWGMKW-UHFFFAOYSA-N

物化性质

• 沸点：
  163-166 °C(Press: 2 Torr)
• 密度：
  1.022±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  18
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.62
• 拓扑面积：
  23.5
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2933399090

反应信息

• 作为反应物：
  描述：

  1-苄基-4-丁基哌啶-4-醇 在 palladium 10% on activated carbon 甲酸铵 作用下， 以 甲醇 为溶剂， 反应 24.5h， 以100%的产率得到4-butyl-4-piperidinol
  参考文献：
  名称：

  Benzimidazolidinone derivatives as muscarinic agents

  摘要：

  苯并咪唑啉酮衍生物化合物，可增加大脑中乙酰胆碱的信号传导或作用，并且高度选择性的肌碱能激动剂，特别是针对M1和/或M4受体亚型，还公开了包含这些化合物的药物组合物，以及使用这些化合物治疗精神病的方法。

  公开号：

  US20040067931A1
• 作为产物：
  描述：

  N-苄基哌啶酮 在 正丁基锂 作用下， 以 乙醚 、 正己烷 、 乙酸乙酯 为溶剂， 生成 1-苄基-4-丁基哌啶-4-醇
  参考文献：
  名称：

  Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting ERAB or HADH2 activity

  摘要：

  由下式表示的吡唑化合物：1。这些吡唑化合物和含有它们的药物组合物可用于抑制ERAB或HADH2活性，并用于治疗ERAB、HADH2或淀粉样蛋白β介导的疾病和症状。

  公开号：

  US20020065292A1

文献信息

• N3-substituted 6-anilinopyrimidines and methods to treat-Gram-positive bacterial and mycoplasmal infections
  申请人：——

  公开号：US20030114445A1

  公开（公告）日：2003-06-19

  Compounds useful for treating Gram-positive bacterial and mycoplasmal infections are disclosed. The compounds have the general formulae shown below. 1

  本发明揭示了用于治疗革兰氏阳性细菌和支原体感染的化合物。该化合物具有下面所示的一般式。1
• Pyridyl alkene and pyridyl alkine- acid amides as cytostatics and immuno-suppressives
  申请人：Biedermann Elfi

  公开号：US20070219197A1

  公开（公告）日：2007-09-20

  The present invention relates to new pyridine compounds, methods for their production, medicaments containing these compounds as well as their use, especially in the treatment of tumor conditions and/or as cytostatic agents or as immunosuppressive agents.

  本发明涉及新的吡啶化合物，其生产方法，含有这些化合物的药物以及它们的用途，特别是在肿瘤病情的治疗中和/或作为细胞毒剂或免疫抑制剂的用途。
• Pyridyl Alkene and Pyridyl Alkine-Acid Amides as Cytostatics and Immunosuppressives
  申请人：Biedermann Elfi

  公开号：US20070142377A1

  公开（公告）日：2007-06-21

  The invention relates to a new pyridyl alkene and pyridyl alkine acid amides according to the general formula (I) as well as methods for their production, medicaments containing these compounds as well as their medical use, especially in the treatment of tumors or for immunosuppression.

  该发明涉及一种新的吡啶基烯和吡啶基炔酸酰胺，其符合通式（I），以及其制备方法，含有这些化合物的药物以及它们在医学上的应用，特别是在肿瘤治疗或免疫抑制方面的应用。
• Synthesis, pharmacological activity and structure affinity relationships of spirocyclic σ1 receptor ligands with a (2-fluoroethyl) residue in 3-position
  作者：Eva Große Maestrup、Christian Wiese、Dirk Schepmann、Peter Brust、Bernhard Wünsch

  DOI：10.1016/j.bmc.2010.11.013

  日期：2011.1

  In order to develop a fluorinated radiotracer for imaging of sigma(1) receptors in the central nervous system a series of (2-fluoroethyl) substituted spirocyclic piperidines 3 has been prepared. In the key step of the synthesis 2-bromocinnamaldehyde acetal 5 was added to piperidones 6 with various substituents at the N-atom. Unexpectedly, this reaction led to 2-benzoxepines 8, which were contracted with acid to afford the spirocyclic 2-benzofuranacetaldehydes 9. The best yields were obtained, when the transformations up to the alcohols 10 were performed without isolation of intermediates. Generally the (2-fluoroethyl) derivatives 3 have higher sigma(1) affinity and sigma(1)/sigma(2) selectivity than the corresponding (3-fluoropropyl) derivatives 2. The most promising candidate for the development as radiotracer is the (2-fluoroethyl) derivative 3a (WMS-1828, fluspidine, 1'-benzyl-3-(2-fluoroethyl)-3H-spiro[[2]benzofuran-1,4'-piperidine]), which shows subnanomolar sigma(1) affinity (K-i = 0.59 nM) and excellent selectivity over the sigma(2) subtype (1331-fold) as well as some other receptor systems. The novel synthetic strategy also allows the systematic pharmacological evaluation of intermediate alcohols 10. Despite their high sigma(1) affinity (K-i = 6-32 nM) and selectivity the alcohols 10 are 10-30-fold less potent than the bioisosteric fluoro derivatives 3. (C) 2010 Elsevier Ltd. All rights reserved.
• Efficient Synthesis of a Highly Selective NPY-5 Receptor Antagonist:  A Drug Candidate for the Treatment of Obesity
  作者：Takahiro Itoh、Shinji Kato、Nobuaki Nonoyama、Toshihiro Wada、Kenji Maeda、Toshiaki Mase、Matthew M. Zhao、Jake Z. Song、David M. Tschaen、James M. McNamara

  DOI：10.1021/op0600963

  日期：2006.7.1

  A concise and practical synthesis of highly selective NPY-5 receptor antagonist 1 is described. The animopyrazine intermediate 3 was synthesized via either monobromination of aminopyrazine or palladium-catalyzed regioselective debromination of dibromopyrazine followed by an efficient Suzuki-Miyaura coupling. For the preparation of the spirolactone piperidine 2, significantly improved yield was achieved by using a combination of n-BuMgCl and n-BuLi. This protocol also dramatically increased the thermal stability of the aryllithium intermediate and eliminated the requirement for costly cryogenic conditions. The union of the spirolactone piperidine 2 and aminopyrazine 3 via a carbonyl group was accomplished using phenyl chloroformate delivering the target molecule in high yield.